Posted: Wed, May 14, 2014 | By: Events
There is a reason that the Rejuvenation Biotechnology Conference: Emerging Regenerative Medicine Solutions for the Diseases of Aging (RB2014), presented by SENS Research Foundation, is coming just a year after SENS6. It’s because RB2014 has a qualitatively different goal than what has gone before. It takes place on August 21rst through 23rd in Santa Clara, California, at the Hyatt Regency Hotel.
It isn’t a SENS progress update, or a broad life extension event. It is, potentially, a bridge, or part of a great bridge over the graveyard that you could be scheduling an appointment at in a few decades. Right now, it seems, most big research machines for the various diseases of aging could do well for themselves and the world to focus more of their efforts on combating the damaging root of them all.
The RB2014 conference is orchestrated and timed so that there is the potential for it to be revolutionary to the various fields involved. It intends to help catalyze an industry based on the application of regenerative medicine to aging. The conference looks at things like ways to more effectively integrate the whole of rejuvenation biotechnology, for example, by further strategizing with complimentary research. Can more cancer and Alzheimer’s laboratories align with the SENS damage approach? A few more partnerships in that way could draw some big dollars. Do industrial technologists have ideas on potential new tools that could be sought out? Policy makers and advocates will have more opportunity to weigh in, helping everybody to understand a broader range of policy concerns. A conference like this can also help us all to conceptualize and understand estimates of bigger picture funding time-tables, and many other complex variables comprising the most efficiently integrated ways forward.
Aging research advocates, disease research advocates, indefinite life extensionists, Transhumanists and groups around the world have been waiting for more integrative conferences with legs, like this one. This is not just a scientific conference, not just a technological conference, but an industrial conference. Tell your health-active colleagues and friends, blog about this, bang a drum somewhere and direct attention to relevant and interested people and groups about its importance.
In life and death causes like this, windows open and close along the way. SENS has now held 6 fantastic conferences, the industry has gotten a good taste of their strong points and successes over the years, and the timing is good. Sometimes you have to hit these kinds of opportunities in stride, you have to come together and get it done while the atmosphere is positive and conducive to it. Economics, public opinion, world shaping events and other things can quickly change the opportunities available to people.
Who do you know that might make for a good speaker at RB2014? Who do you know that you might be able to get to register to attend? Do you know a reporter or blogger within 200 miles of the Santa Clara area that you might be able to help get to the event? There are many ways you can lend a hand. If you aren’t too far from Santa Clara, California, then print these presentation submission and registration flyers out and pin them up at your local universities and hospitals.
There is an early bird special for registering before June 30th. You can also receive an additional 25% off with a special promotional code that you can get in any comments section where this is posted.
Rejuvenation Biotechnology Conference: Emerging Regenerative Medicine Solutions for the Diseases of Aging press release from the SENS Research Foundation:
REGISTRATION NOW OPEN FOR 2014 REJUVENATION BIOTECHNOLOGY CONFERENCE
MOUNTAIN VIEW, Calif. — April 11, 2014 — The SENS Research Foundation announced today that registration is now open for the Rejuvenation Biotechnology Conference, to be held August 21 - 23, 2014 at the Hyatt Regency Santa Clara in Santa Clara, California. Information about the conference can be found at http://sens.org/rb2014.
The theme for the Rejuvenation Biotechnology Conference is Emerging Regenerative Medicine Solutions for the Diseases of Aging. The Rejuvenation Biotechnology Conference builds upon novel strategies being pioneered by the Alzheimer’s and cancer communities by convening the foremost leaders from academia, industry, investment, policy, and advocacy from multiple disease communities to consider the wider potential of these strategies and evaluate the feasibility of preventative and combinatorial medicine applications to treat all aging-related diseases.
The conference will feature over 50 leading speakers from industry, academia, government and the financial community. Confirmed speakers include:
- Richard Barker CASMI
- Maria Blasco, Spanish National Cancer Research Centre
- George Church, Harvard Medical School
- Aubrey de Grey, SENS Research Foundation
- Laura Esserman, UCSF
- Caleb Finch, USC Davis School of Gerontology
- W. Gray Jerome, Vanderbilt University Medical School
- Jeffrey Karp, Harvard Medical School
- Jeanne Loring, Scripps Research Institute
- Stephen Minger, GE Healthcare Life Sciences, UK
- Brock Reeve, Harvard Stem Cell Institute
- David Schaffer, University of California Berkeley
- Evan Snyder, Sanford/Burnham Medical Research Institute
- Matthias Steger, Hoffmann-La Roche
- Michael West, Biotime, Inc.
Registration is now open, with early bird rates in effect through June 30, 2014. For more information, visit http://sens.org/RB2014. Sponsorships for the conference are also currently available, contact firstname.lastname@example.org for more information.
About the SENS Research Foundation (SRF)
SENS Research Foundation is a 501(c)(3) nonprofit that works to research, develop and promote comprehensive regenerative medicine solutions for the diseases of aging. SENS Research Foundation is focused on a damage repair paradigm for treating the diseases of aging, which it advances through scientific research, advocacy and education. SENS Research Foundation supports research projects at its Mountain View Research Center, universities and institutes around the world with the goal of curing such age-related diseases as macular degeneration, heart disease, cancer, and Alzheimer’s disease. Educating the public and training researchers to support a growing regenerative medicine field are also major endeavors of the organization that are being accomplished though advocacy campaigns and educational programs. For more information, visit www.sens.org.